FDA Inspections of Foreign Drug Manufacturers Haven’t Bounced Back After Pandemic
The FDA hasn’t recovered from its pause in foreign drug manufacturer inspections during the COVID-19 pandemic, with inspections in 2022 remaining “well below” pre-pandemic surveillance levels, a study found. Researchers tracking a decade of FDA inspections observed an expected decline in inspections in 2020, but 2 years later foreign inspections remained 79% lower than 2019, […]